Sierra M. Acosta
Lawyers
Filters
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
REGENXBIO $140 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Intercontinental Exchange consent solicitation
The consent solicitation involves notes due 2028
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market
Mohawk Industries $600 million notes offering
The 5.85% senior notes are due 2028
Rollins $1.3 billion inaugural secondary offering
The shares are listed on the New York Stock Exchange
Madison Dearborn Partners $1.05 billion MoneyGram acquisition financing
We advised on the loan financing and notes offering in connection with the acquisition of MoneyGram International
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
Arrow Electronics $500 million senior notes offering
The 6.125% investment-grade senior notes are due 2026